Barbara Klencke
Directeur/Membre du Conseil chez EFFECTOR THERAPEUTICS, INC.
Fortune : 400 950 $ au 30/04/2024
Profil
Barbara J.
Klencke is currently a Director at Xencor, Inc., a Director at Immune-Onc Therapeutics, Inc., an Independent Director at TScan Therapeutics, Inc., and an Independent Director at eFFECTOR Therapeutics, Inc. Previously, she held positions such as Medical Director at Chiron Corp., Group Medical Director-Product Development at Genentech, Inc., Senior Vice President-Clinical Development at Onyx Pharmaceuticals, Inc., and Chief Medical & Development Officer at Sierra Oncology, Inc. She also served as an Independent Director at Lexent Bio, Inc. Dr. Klencke received her undergraduate degree from Indiana University and her doctorate from the University of California, Davis.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TSCAN THERAPEUTICS, INC.
0,12% | 14/12/2023 | 55 000 ( 0,12% ) | 400 950 $ | 30/04/2024 |
| 18/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Barbara Klencke
| Sociétés | Poste | Début |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2021 |
| TSCAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/04/2023 |
| XENCOR, INC. | Directeur/Membre du Conseil | 15/09/2023 |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Directeur/Membre du Conseil | 08/11/2022 |
Anciens postes connus de Barbara Klencke
| Sociétés | Poste | Fin |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/07/2022 |
Lexent Bio, Inc.
 Lexent Bio, Inc. Financial ConglomeratesFinance Lexent Bio, Inc. engages in the development of novel liquid biopsy technologies to manage cancer. The company was founded by Kenneth G. Nesmith, Haluk Tezcan, and John Spinosa and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | 01/01/2020 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/06/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2011 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/07/2003 |
Formation de Barbara Klencke
| Indiana University | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Lexent Bio, Inc.
Lexent Bio, Inc. Financial ConglomeratesFinance Lexent Bio, Inc. engages in the development of novel liquid biopsy technologies to manage cancer. The company was founded by Kenneth G. Nesmith, Haluk Tezcan, and John Spinosa and is headquartered in San Francisco, CA. | Finance |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Health Technology |
